These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1165476)

  • 41. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental allergic encephalomyelitis (EAE) in two inbred guinea pigs. II. Strain differences in susceptibility to passive transfer of EAE.
    Fujiwara S; Fujiwara M; Ohtani S
    Jpn J Exp Med; 1981 Feb; 51(1):17-20. PubMed ID: 7311076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein.
    Buschman E; van Oers N; Katz M; Murgita RA
    J Neuroimmunol; 1987 Jan; 13(3):315-30. PubMed ID: 2432086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proceedings: Animal model for myasthenia gravis: acetylcholine receptor-induced myasthenia in rabbits, guinea pigs and monkeys.
    Tarrab-Hazdai R; Aharonov A; Abramsky O; Silman I; Fuchs S
    Isr J Med Sci; 1975 Dec; 11(12):1390. PubMed ID: 815200
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G; Gomez CM
    J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.
    Paas-Rozner M; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12642-7. PubMed ID: 11606745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
    Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
    N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.
    Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
    J Clin Invest; 1997 Dec; 100(12):3027-35. PubMed ID: 9399949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune rat T lymphocytes monospecific for acetylcholine receptors: purification and fine specificity.
    Hohlfeld R; Kalies I; Heinz F; Kalden JR; Wekerle H
    J Immunol; 1981 Apr; 126(4):1355-9. PubMed ID: 6162888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cellular immunology of myasthenia gravis.
    Willcox N
    Ric Clin Lab; 1985; 15(3):199-204. PubMed ID: 3878566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental autoimmune myasthenia: clinical, neurophysiologic, and pharmacologic aspects.
    Seybold ME; Lambert EH; Lennon VA; Lindstrom JM
    Ann N Y Acad Sci; 1976; 274():275-82. PubMed ID: 1066989
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of tumor growth in an "immunologically privileged site" by adoptive transfer of tumor-specific transplantation immunity.
    Futrell JW; Albright NL; Myers GH
    J Surg Res; 1972 Feb; 12(2):62-9. PubMed ID: 5012043
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis.
    Namba T; Arimori S; Grob D
    Neurology; 1969 May; 19(5):461-8. PubMed ID: 5815220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.